These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 18230615)
1. A potent HIV protease inhibitor, darunavir, does not inhibit ZMPSTE24 or lead to an accumulation of farnesyl-prelamin A in cells. Coffinier C; Hudon SE; Lee R; Farber EA; Nobumori C; Miner JH; Andres DA; Spielmann HP; Hrycyna CA; Fong LG; Young SG J Biol Chem; 2008 Apr; 283(15):9797-804. PubMed ID: 18230615 [TBL] [Abstract][Full Text] [Related]
2. HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells. Coffinier C; Hudon SE; Farber EA; Chang SY; Hrycyna CA; Young SG; Fong LG Proc Natl Acad Sci U S A; 2007 Aug; 104(33):13432-7. PubMed ID: 17652517 [TBL] [Abstract][Full Text] [Related]
3. HIV-protease inhibitors block the enzymatic activity of purified Ste24p. Hudon SE; Coffinier C; Michaelis S; Fong LG; Young SG; Hrycyna CA Biochem Biophys Res Commun; 2008 Sep; 374(2):365-8. PubMed ID: 18639527 [TBL] [Abstract][Full Text] [Related]
4. HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy? Goulbourne CN; Vaux DJ Biochem Soc Trans; 2010 Feb; 38(Pt 1):292-6. PubMed ID: 20074077 [TBL] [Abstract][Full Text] [Related]
5. Inhibitors of protein geranylgeranyltransferase-I lead to prelamin A accumulation in cells by inhibiting ZMPSTE24. Chang SY; Hudon-Miller SE; Yang SH; Jung HJ; Lee JM; Farber E; Subramanian T; Andres DA; Spielmann HP; Hrycyna CA; Young SG; Fong LG J Lipid Res; 2012 Jun; 53(6):1176-82. PubMed ID: 22448028 [TBL] [Abstract][Full Text] [Related]
6. LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation. Afonso P; Auclair M; Boccara F; Vantyghem MC; Katlama C; Capeau J; Vigouroux C; Caron-Debarle M Atherosclerosis; 2016 Feb; 245():200-11. PubMed ID: 26724531 [TBL] [Abstract][Full Text] [Related]
7. HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" study. Perrin S; Cremer J; Faucher O; Reynes J; Dellamonica P; Micallef J; Solas C; Lacarelle B; Stretti C; Kaspi E; Robaglia-Schlupp A; Nicolino-Brunet C; Tamalet C; Lévy N; Poizot-Martin I; Cau P; Roll P PLoS One; 2012; 7(12):e53035. PubMed ID: 23285253 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial. Madruga JV; Berger D; McMurchie M; Suter F; Banhegyi D; Ruxrungtham K; Norris D; Lefebvre E; de Béthune MP; Tomaka F; De Pauw M; Vangeneugden T; Spinosa-Guzman S; Lancet; 2007 Jul; 370(9581):49-58. PubMed ID: 17617272 [TBL] [Abstract][Full Text] [Related]
9. Type B mandibuloacral dysplasia with congenital myopathy due to homozygous ZMPSTE24 missense mutation. Ben Yaou R; Navarro C; Quijano-Roy S; Bertrand AT; Massart C; De Sandre-Giovannoli A; Cadiñanos J; Mamchaoui K; Butler-Browne G; Estournet B; Richard P; Barois A; Lévy N; Bonne G Eur J Hum Genet; 2011 Jun; 19(6):647-54. PubMed ID: 21267004 [TBL] [Abstract][Full Text] [Related]
10. [Darunavir in treatment-naïve patients. The ARTEMIS study]. Estrada V; Fuster M Enferm Infecc Microbiol Clin; 2008 Oct; 26 Suppl 10():10-3. PubMed ID: 19195454 [TBL] [Abstract][Full Text] [Related]
11. Deficiency in ZMPSTE24 and resulting farnesyl-prelamin A accumulation only modestly affect mouse adipose tissue stores. Heizer PJ; Yang Y; Tu Y; Kim PH; Chen NY; Hu Y; Yoshinaga Y; de Jong PJ; Vergnes L; Morales JE; Li RL; Jackson N; Reue K; Young SG; Fong LG J Lipid Res; 2020 Mar; 61(3):413-421. PubMed ID: 31941672 [TBL] [Abstract][Full Text] [Related]
12. Effects of ritonavir-boosted darunavir, atazanavir and lopinavir on adipose functions and insulin sensitivity in murine and human adipocytes. Capel E; Auclair M; Caron-Debarle M; Capeau J Antivir Ther; 2012; 17(3):549-56. PubMed ID: 22293506 [TBL] [Abstract][Full Text] [Related]
13. Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice. Fong LG; Ng JK; Meta M; Coté N; Yang SH; Stewart CL; Sullivan T; Burghardt A; Majumdar S; Reue K; Bergo MO; Young SG Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18111-6. PubMed ID: 15608054 [TBL] [Abstract][Full Text] [Related]
14. Abolishing the prelamin A ZMPSTE24 cleavage site leads to progeroid phenotypes with near-normal longevity in mice. Wang Y; Shilagardi K; Hsu T; Odinammadu KO; Maruyama T; Wu W; Lin CS; Damoci CB; Spear ED; Shin JY; Hsu W; Michaelis S; Worman HJ Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35197292 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study Group. Curran A; Monteiro P; Domingo P; Villar J; Imaz A; Martínez E; Fernández I; Knobel H; Podzamczer D; Iribarren JA; Peñaranda M; Crespo M; J Antimicrob Chemother; 2014 May; 69(5):1390-6. PubMed ID: 24415645 [TBL] [Abstract][Full Text] [Related]
16. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes. Toth JI; Yang SH; Qiao X; Beigneux AP; Gelb MH; Moulson CL; Miner JH; Young SG; Fong LG Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12873-8. PubMed ID: 16129834 [TBL] [Abstract][Full Text] [Related]
17. Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Agarwal AK; Fryns JP; Auchus RJ; Garg A Hum Mol Genet; 2003 Aug; 12(16):1995-2001. PubMed ID: 12913070 [TBL] [Abstract][Full Text] [Related]
18. Proteomic profiling of adipose tissue from Zmpste24-/- mice, a model of lipodystrophy and premature aging, reveals major changes in mitochondrial function and vimentin processing. Peinado JR; Quirós PM; Pulido MR; Mariño G; Martínez-Chantar ML; Vázquez-Martínez R; Freije JM; López-Otín C; Malagón MM Mol Cell Proteomics; 2011 Nov; 10(11):M111.008094. PubMed ID: 21828285 [TBL] [Abstract][Full Text] [Related]
19. [Safety and tolerability of darunavir]. Antela López A Enferm Infecc Microbiol Clin; 2008 Oct; 26 Suppl 10():32-6. PubMed ID: 19195457 [TBL] [Abstract][Full Text] [Related]
20. Lopinavir/ritonavir: appraisal of its use in HIV therapy. von Hentig N Drugs Today (Barc); 2007 Apr; 43(4):221-47. PubMed ID: 17460785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]